Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Brigit Biofarmaka Teknologi TbkISX:OBAT -0.82% Earnings Yield (Joel Greenblatt) % is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 2,030 Consumer Packaged Goods companies, PT Brigit Biofarmaka Teknologi Tbk ranks worse than 76.4% on this metric.
PT Brigit Biofarmaka Teknologi Tbk's Enterprise Value for the quarter that ended in . 20 was Rp0.00 Mil.
PT Brigit Biofarmaka Teknologi Tbk does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) at this moment.
The historical rank and industry rank for PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ISX:OBAT's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 6.03 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. PT Brigit Biofarmaka Teknologi Tbk's Forward Rate of Return (Yacktman) % for the quarter that ended in . 20 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Earnings Yield (Joel Greenblatt) %
ISX:OBAT vs KHC, GIS: Earnings Yield (Joel Greenblatt) % Comparison
For the Packaged Foods subindustry, PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Brigit Biofarmaka Teknologi Tbk Earnings Yield (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
What does a Earnings Yield (Joel Greenblatt) % of 0.00% mean?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Earnings Yield (Joel Greenblatt) % of 0.00% as of . 20. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. According to the industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #1551 out of 2030 companies in the Consumer Packaged Goods industry, placing it in the top 76.4%.
Is PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) % too high?
PT Brigit Biofarmaka Teknologi Tbk's current Earnings Yield (Joel Greenblatt) % is 0.00%. Based on the distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #1551 out of 2030 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PT Brigit Biofarmaka Teknologi Tbk's Earnings Yield (Joel Greenblatt) % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #1551 out of 2030 companies for Earnings Yield (Joel Greenblatt) %. This places PT Brigit Biofarmaka Teknologi Tbk in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median Earnings Yield (Joel Greenblatt) % among Consumer Packaged Goods companies is 6.03, based on 2,030 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. For the Consumer Packaged Goods industry, the median Earnings Yield (Joel Greenblatt) % is 6.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Brigit Biofarmaka Teknologi Tbk's current Earnings Yield (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Earnings Yield (Joel Greenblatt) % of 0.00%. The current Earnings Yield (Joel Greenblatt) % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Earnings Yield (Joel Greenblatt) % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OBAT has been successfully added to your 
